Journal of Nutrition Animal Diets/Enrichment Products...

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dejong, C. H. C.
Right arrow Articles by Olde Damink, S. W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dejong, C. H. C.
Right arrow Articles by Olde Damink, S. W. M.
© 2007 American Society for Nutrition J. Nutr. 137:1579S-1585S, June 2007


Supplement: Aromatic Amino Acids and Related Substances: Chemistry, Biology, Medicine, and Application: SESSION 4

Aromatic Amino Acid Metabolism during Liver Failure1–3,

Cornelis H. C. Dejong4,*, Marcel C. G. van de Poll4, Peter B. Soeters4, Rajiv Jalan5 and Steven W. M. Olde Damink4

4 Department of Surgery, Nutrition and Toxicology Institute Maastricht, Maastricht University and University Hospital Maastricht, Maastricht 6202 AZ, the Netherlands; and 5 Institute of Hepatology, Royal Free and University College Medical School, University College London, London WC1 6Hx, UK

* To whom correspondence should be addressed. E-mail: chc.dejong{at}ah.unimaas.nl.

Liver failure is associated with hepatic encephalopathy (HE). An imbalance in plasma levels of aromatic amino acids (AAA) phenylalanine, tyrosine, and tryptophan and branched chain amino acids (BCAA) and their BCAA/AAA ratio has been suggested to play a causal role in HE by enhanced brain AAA uptake and subsequently disturbed neurotransmission. Until recently, data on this subject and the role of the liver and splanchnic bed were scarce, particularly in humans, due to inaccessibility of portal and hepatic veins. Here, we discuss, against a background of relevant literature, data obtained in patients undergoing liver resection or with a transjugular intrahepatic portasystemic stent shunt (TIPSS), where these veins are accessible. The BCAA/AAA ratio remained unchanged after major liver resection, but plasma AAA levels were inversely correlated (P < 0.001) with residual liver volume, in keeping with the observed hepatic AAA uptake. In patients with stable cirrhosis and a TIPSS, the plasma BCAA/AAA ratio was lower than in controls (1.19 ± 0.09 vs. controls: 3.63 ± 0.34). Gastrointestinal bleeding in cirrhotics with a TIPSS induced disturbances in BCAA levels and the BCAA/AAA ratio and induced catabolism, which could partly be corrected by isoleucine administration. AAA may be important in the pathogenesis of HE, but it is unlikely that they are the sole factors. HE most likely is a syndrome with multifactorial pathogenesis, where hyperammonemia, AAA/BCAA imbalances, inflammation, brain edema, and neurotransmitter changes interact. Novel therapies to normalize AAA levels in patients with liver failure (such as the molecular adsorbent recirculating system dialysis device) should probably be combined with supplementation of e.g. isoleucine and enhancing ammonia excretion by the kidneys.





This article has been cited by other articles:


Home page
Nutr Clin PractHome page
Y. Chen and S. J. Peterson
Enteral Nutrition Formulas: Which Formula Is Right for Your Adult Patient?
Nutr Clin Pract, June 1, 2009; 24(3): 344 - 355.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. C. G. van de Poll, G. C. Ligthart-Melis, S. W. M. Olde Damink, P. A. M. van Leeuwen, R. G. H. Beets-Tan, N. E. P. Deutz, S. J. Wigmore, P. B. Soeters, and C. H. C. Dejong
The gut does not contribute to systemic ammonia release in humans without portosystemic shunting
Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G760 - G765.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
P. Tessari, E. Kiwanuka, M. Vettore, R. Barazzoni, M. Zanetti, D. Cecchet, and R. Orlando
Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion
Am J Physiol Gastrointest Liver Physiol, September 1, 2008; 295(3): G598 - G604.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. Takai
Introduction to the Transdisciplinary International Conference on Aromatic Amino Acids and Related Substances: Chemistry, Biology, Medicine, and Application
J. Nutr., June 1, 2007; 137(6): 1501S - 1503S.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2007 by American Society for Nutrition